Connect with us
Information

WORLD EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

WORLD EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

rare pediatric disease designation

POPULAR ARTICLES

Cellectar’s CLR 131 Receives FDA Orphan Drug Designation for the Treatment of Pediatric Osteosarcoma

FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Osteosarcoma

Krystal Biotechs’ KB105 Receives Rare Pediatric Disease Designation from the FDA to Treat Patients with TGM-1-deficient Autosomal Recessive Congenital Ichthyosis

LATEST ARTICLES

pharmaceutical investing

FDA Grants Rare Pediatric Disease Designation to A4250; Albireo Eligible to Apply for Priority Review Voucher

Latest News

Operations update with mine production up 25% QoQ

Empire Metals Limited Announces Team Expansion & Bulk Met Testing Commences

Surface Metals: Gold and Lithium Portfolios in North America’s Most Strategic Jurisdictions

SAGA Metals Showcases Radar Project as Potentially Comparable to China's Panzhihua VTM Deposit

Forte Minerals Secures C$5.7 Million Strategic Investment to Advance Alto Ruri Project

Outlook Reports

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Surface Metals

SUR:CC

Maritime Resources

MAE:CC

Triumph Gold

TIG:CA

Quimbaya Gold

QIM:CC

New Age Exploration

NAE:AU

Asara Resources

AS1:AU

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES